Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M S Cragg

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Oncogene|August 3, 2010
MOS, aneuploidy and the ploidy cycle of cancer cellsJ Erenpreisa, M S Cragg
Cancer Cell International|May 2, 2002
Mitotic death: a mechanism of survival? A reviewJekaterina Erenpreisa, M S Cragg
Seminars in Cancer Biology|April 15, 1999
Molecular markers of B-cell lymphomaG T Stevenson, M S Cragg
Cell Biology International|November 29, 2005
Mitotic catastrophe and endomitosis in tumour cells: an evolutionary key to a molecular solutionJekaterina Erenpreisa, M Kalejs, M S Cragg
Current Opinion in Immunology|October 6, 1999
Signaling antibodies in cancer therapyM S Cragg, R R French, M J Glennie
Scandinavian Journal of Immunology|January 28, 2017
Lack of Fc Gamma Receptor IIIA Promotes Rather than Suppresses Humoral and Cellular Immune Responses after Mucosal or Parenteral Immunization with Antigen and AdjuvantsJ-B Sun, J Holmgren, M S Cragg, et al.
British Journal of Cancer|March 10, 1999
Analysis of the interaction of monoclonal antibodies with surface IgM on neoplastic B-cellsM S Cragg, L Zhang, R R French, et al.
Scandinavian Journal of Immunology|June 1, 2017
Anti-FcγRIIB (CD32) Antibodies Differentially Modulate Murine FVIII-Specific Recall Response in vitroN Vollack, J Friese, S Bergmann, et al.
Cell Biology International|August 31, 2000
Polyploid giant cells provide a survival mechanism for p53 mutant cells after DNA damageT M Illidge, M S Cragg, B Fringes, et al.
Cell Biology International|August 31, 2000
Release of mitotic descendants by giant cells from irradiated Burkitt's lymphoma cell lineJ A Erenpreisa, M S Cragg, B Fringes, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Oncogene|August 3, 2010
MOS, aneuploidy and the ploidy cycle of cancer cellsJ Erenpreisa, M S Cragg
Cancer Cell International|May 2, 2002
Mitotic death: a mechanism of survival? A reviewJekaterina Erenpreisa, M S Cragg
Seminars in Cancer Biology|April 15, 1999
Molecular markers of B-cell lymphomaG T Stevenson, M S Cragg
Cell Biology International|November 29, 2005
Mitotic catastrophe and endomitosis in tumour cells: an evolutionary key to a molecular solutionJekaterina Erenpreisa, M Kalejs, M S Cragg
Current Opinion in Immunology|October 6, 1999
Signaling antibodies in cancer therapyM S Cragg, R R French, M J Glennie
Scandinavian Journal of Immunology|January 28, 2017
Lack of Fc Gamma Receptor IIIA Promotes Rather than Suppresses Humoral and Cellular Immune Responses after Mucosal or Parenteral Immunization with Antigen and AdjuvantsJ-B Sun, J Holmgren, M S Cragg, et al.
British Journal of Cancer|March 10, 1999
Analysis of the interaction of monoclonal antibodies with surface IgM on neoplastic B-cellsM S Cragg, L Zhang, R R French, et al.
Scandinavian Journal of Immunology|June 1, 2017
Anti-FcγRIIB (CD32) Antibodies Differentially Modulate Murine FVIII-Specific Recall Response in vitroN Vollack, J Friese, S Bergmann, et al.
Cell Biology International|August 31, 2000
Polyploid giant cells provide a survival mechanism for p53 mutant cells after DNA damageT M Illidge, M S Cragg, B Fringes, et al.
Cell Biology International|August 31, 2000
Release of mitotic descendants by giant cells from irradiated Burkitt's lymphoma cell lineJ A Erenpreisa, M S Cragg, B Fringes, et al.
Pageof 3